Literature DB >> 14655174

USRDS: the United States Renal Data System.

.   

Abstract

Mesh：

Year:  2003        PMID： 14655174

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  53 in total

Review 1.  Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.

Authors:  Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2007-12-08       Impact factor: 2.370

2.  Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.

Authors:  P Y Chuang; Q Yu; W Fang; J Uribarri; J C He
Journal:  Kidney Int       Date:  2007-08-01       Impact factor: 10.612

3.  The hyperglycemic and hyperinsulinemic combo gives you diabetic kidney disease immediately. Focus on "Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney".

Authors:  Seung Hyeok Han; Katalin Susztak
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 4.  Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.

Authors:  Leonidas H Duntas; Nikolaos Stathatos
Journal:  Endocrine       Date:  2011-03-26       Impact factor: 3.633

5.  Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.

Authors:  Kapil Kampe; Jonas Sieber; Jana Marina Orellana; Peter Mundel; Andreas Werner Jehle
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-11

6.  DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.

Authors:  Aili Cao; Jianhua Li; Morad Asadi; John M Basgen; Bingbing Zhu; Zhengzi Yi; Song Jiang; Tomohito Doke; Osama El Shamy; Niralee Patel; Paolo Cravedi; Evren U Azeloglu; Kirk N Campbell; Madhav Menon; Steve Coca; Weijia Zhang; Hao Wang; Ke Zen; Zhihong Liu; Barbara Murphy; John C He; Vivette D D'Agati; Katalin Susztak; Lewis Kaufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

7.  Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

Authors:  Jeffrey J Olearczyk; Jeffrey E Quigley; Bradford C Mitchell; Tatsuo Yamamoto; In-Hae Kim; John W Newman; Ayala Luria; Bruce D Hammock; John D Imig
Journal:  Clin Sci (Lond)       Date:  2009-01       Impact factor: 6.124

Review 8.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

9.  Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus.

Authors:  Qijin Zhu; Xiangming Qi; Yonggui Wu; Kun Wang
Journal:  Int Urol Nephrol       Date:  2016-06-24       Impact factor: 2.370

10.  Pirfenidone is renoprotective in diabetic kidney disease.

Authors:  Satish P RamachandraRao; Yanqing Zhu; Timothy Ravasi; Tracy A McGowan; Irene Toh; Stephen R Dunn; Shinichi Okada; Michael A Shaw; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.